Forbion Capital Partners and Life Science Partners (LSP) have co-led a EUR 9.5m series-A funding round for biopharmaceutical firm arGEN-X, alongside KBC Private Equity, BioGeneration Ventures and existing shareholders Erasmus MC Biomedical Fund and Thuja Capital Healthcare Funds.
Glass Container companies are portfolio companies of Horizon Capital’s Western NIS Enterprise Fund
Seed investor Heartbeat Labs will retain a 10% stake in Fernarzt
Innovery is a portfolio company of Wisequity IV, which closed on €215m and is currently 92% deployed
Fund will be larger than its predecessor, which closed on €280m in July 2018